News
In recent years, the analysis of single-cell and spatial data has revolutionized biomedical research, making it possible to ...
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
FDA designates MB-101 CAR T-cell therapy for glioblastoma, highlighting its potential in treating aggressive brain tumors ...
After Decades Without Progress in Glioblastoma, Diakonos Stirs Up Interest in Dendritic Cell Vaccine
The firm is launching a Phase II trial of its dendritic cell vaccine following promising preliminary efficacy and favorable safety results in Phase I.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results